Spots Global Cancer Trial Database for motexafin gadolinium
Every month we try and update this database with for motexafin gadolinium cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00387790 | Untreated Child... | motexafin gadol... 3-dimensional c... | - 21 Years | National Cancer Institute (NCI) | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00290004 | Chronic Lymphoc... Small Lymphocyt... Leukemia Lymphoma | motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | NCT00003909 | Untreated Child... | motexafin gadol... radiation thera... pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme | NCT00004262 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | conventional su... 3-dimensional c... stereotactic ra... motexafin gadol... magnetic resona... spectroscopy | 18 Years - | National Cancer Institute (NCI) | |
| Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00003409 | Brain and Centr... | motexafin gadol... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00514397 | Brain and Centr... | motexafin gadol... temozolomide adjuvant therap... quality-of-life... radiation thera... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | NCT00305864 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | 3-Dimensional C... Motexafin Gadol... Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | NCT00003798 | Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas | NCT00003410 | Brain and Centr... | motexafin gadol... magnetic resona... surgical proced... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | NCT00086034 | Lymphoma Non-Hodgkin's L... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer | NCT01562223 | Prostate Cancer | motexafin gadol... | 18 Years - | American College of Radiology Imaging Network | |
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | NCT00129844 | Adenocarcinoma Non-Small-Cell ... Lung Neoplasms | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma | NCT01549886 | Non-Hodgkin's L... | Y-90-Zevalin Moxtezafin Gado... Rituximab | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer | NCT00003736 | Breast Cancer | motexafin gadol... biopsy breast imaging ... comparison of s... magnetic resona... study of high r... | 25 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain | NCT00032097 | Brain and Centr... | motexafin gadol... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00100711 | Chronic Lymphoc... Small Lymphocyt... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | NCT00086034 | Lymphoma Non-Hodgkin's L... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL | NCT00089284 | Non-Hodgkin's L... | Rituxan motexafin gadol... 111Indium-Zeval... | 18 Years - | Northwestern University | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | NCT00003798 | Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL | NCT00734773 | Brain and Centr... Lymphoma Neurotoxicity | Rituximab Cytarabine Methotrexate Motexafin gadol... Procarbazine hy... Vincristine sul... Radiation thera... | 18 Years - | Northwestern University | |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | NCT00005065 | Stage IIIA Non-... | paclitaxel carboplatin motexafin gadol... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer | NCT00003736 | Breast Cancer | motexafin gadol... biopsy breast imaging ... comparison of s... magnetic resona... study of high r... | 25 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma | NCT00387790 | Untreated Child... | motexafin gadol... 3-dimensional c... | - 21 Years | National Cancer Institute (NCI) | |
| Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme | NCT00004262 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | conventional su... 3-dimensional c... stereotactic ra... motexafin gadol... magnetic resona... spectroscopy | 18 Years - | National Cancer Institute (NCI) | |
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | NCT00129844 | Adenocarcinoma Non-Small-Cell ... Lung Neoplasms | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) | NCT00076401 | Leukemia Leukemia, Lymph... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00290004 | Chronic Lymphoc... Small Lymphocyt... Leukemia Lymphoma | motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00022256 | Brain and Centr... | motexafin gadol... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma | NCT01549886 | Non-Hodgkin's L... | Y-90-Zevalin Moxtezafin Gado... Rituximab | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
